Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SCN1A | P35498 | 1/20 | 0.40 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1535633 | 0.91 | GAA (0.61) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL20711670 | 0.88 | GAA (0.56) | GAAHTTTSHRCA1CA2 | |
| SCHEMBL19720327 | 0.87 | TSHR (0.50) | GAAHTTTSHRCA1CA2 | |
| SCHEMBL13474871 | 0.87 | TSHR (0.56) | GAAHTTTSHRCA1CA2 | |
| SCHEMBL13554252 | 0.86 | TSHR (0.58) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL19976793 | 0.85 | GAA (0.56) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL13554333 | 0.85 | SCN1A (0.56) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL13126360 | 0.85 | TSHR (0.57) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL19884590 | 0.84 | GAA (0.54) | GAAHTTTSHRALDH1A1ESR1 | |
| SCHEMBL243559 | 0.84 | TSHR (0.70) | GAAHTTTSHRALDH1A1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11312908-B2 | Liquid crystal medium and liquid crystal display | MERCK PATENT GMBH (DE) | 2022-04-26 | — | — | US | disclosed |
| US-11015123-B2 | Liquid-crystal material | MERCK PATENT GMBH (DE) | 2021-05-25 | — | — | US | disclosed |
| EP-3327103-B1 | LIQUID CRYSTAL MEDIUM, METHOD FOR THE STABILISATION THEREOF AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2020-10-14 | — | — | EP | disclosed |
| US-20200255741-A1 | LIQUID-CRYSTAL MATERIAL | MERCK PATENT GMBH (DE) | 2020-08-13 | — | — | US | disclosed |
| EP-3458549-B1 | LIQUID-CRYSTAL MATERIAL | MERCK PATENT GMBH (DE) | 2020-07-22 | — | — | EP | disclosed |
| US-20200056093-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND ELECTRONIC DEVICE | SHARP KABUSHIKI KAISHA (JP) | 2020-02-20 | — | — | US | disclosed |
| US-10465117-B2 | Liquid-crystalline medium, method for the stabilization thereof, and liquid-crystal display | MERCK PATENT GMBH (DE) | 2019-11-05 | — | — | US | disclosed |
| US-10189928-B2 | Curable composition, pattern forming method, pattern, and method for manufacturing device | FUJIFILM CORPORATION (JP) | 2019-01-29 | — | — | US | disclosed |
| US-20180163134-A1 | LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2018-06-14 | — | — | US | disclosed |
| EP-3327102-A1 | LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2018-05-30 | — | — | EP | disclosed |
| US-9388339-B2 | Liquid-crystalline medium, method for the stabilization thereof, and liquid-crystal display | MERCK PATENT GMBH (DE) | 2016-07-12 | — | — | US | disclosed |
| US-20150184077-A1 | LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2015-07-02 | — | — | US | disclosed |
| US-20150159088-A1 | COMPOUNDS AND LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2015-06-11 | — | — | US | disclosed |
| US-8999460-B2 | Compounds and liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2015-04-07 | — | — | US | disclosed |
| US-8962102-B2 | — | — | 2015-02-24 | — | — | US | disclosed |
| EP-2514800-B1 | Compounds and liquid crystalline medium | MERCK PATENT GMBH (DE) | 2014-10-29 | — | — | EP | disclosed |
| US-20140111730-A1 | Liquid-crystalline medium, method for the stabilization thereof, and liquid-crystal display | MERCK PATENT GMBH (DE) | 2014-04-24 | — | — | US | disclosed |
| EP-2722381-A2 | Liquid crystal medium, method for the stabilisation thereof and liquid crystal display | Merck Patent GmbH (DE) | 2014-04-23 | — | — | EP | disclosed |
| EP-2722380-A2 | Liquid crystal medium, method for the stabilisation thereof and liquid crystal display | Merck Patent GmbH (DE) | 2014-04-23 | — | — | EP | disclosed |
| US-20120268706-A1 | COMPOUNDS AND LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150159088-A1 | COMPOUNDS AND LIQUID-CRYSTALLINE MEDIUM | VIM, NEFM, VCL | GAA 3565/4885HTT 3107/4885TSHR 4352/4885 |
| US-20120268706-A1 | COMPOUNDS AND LIQUID-CRYSTALLINE MEDIUM | NEFM, VIM, FLNB | GAA 4098/4885HTT 2837/4885TSHR 4504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.